Characterization of two cloned human CB1 cannabinoid receptor isoforms

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 2, 1996, Pages 871-878

  Rinaldi Carmona, Murielle ^a   Calandra, Bernard ^a   Shire, David ^a   Bouaboula, Monsif ^a   Oustric, Didier ^a   Barth, Francis ^a   Casellas, Pierre ^a   Ferrara, Pascual ^a   Le Fur, Gérard ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; ANANDAMIDE; BOVINE SERUM ALBUMIN; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CYCLIC AMP; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; RIMONABANT; TETRAHYDROCANNABINOL;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS; ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CHO CELLS; CRICETINAE; CYCLIC AMP; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; HUMANS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0030440971     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. BOUABOULA, M., RINALDI, M., CARAYON, P., CARILLON, C., DELPECH, B., SHIRE, D., LE FUR, G. AND CASELLAS, P.: Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214: 173-180, 1993.
2. BOUABOULA, M., BOURRIÉ, B., RINALDI-CARMONA, M., SHIRE, D., LE FUR, G. AND CASELLAS, P.: Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J. Biol. Chem. 270: 13973-13980, 1995a.
3. BOUABOULA, M., POINOT-CHAZEL, C., BOURRIÉ, B., CANAT, X., CALANDRA, B., RINALDI-CARMONA, M., LE FUR, G. AND CASELLAS, P.: Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J. 312: 637-641, 1995b.
4. CRESPO, P., XU, N., SIMONDS, W. F. AND GUTKIND, J. S.: Ras-dependent activation of MAP kinase pathway mediated by G-protein subunits. Nature 369: 418-420, 1994.
5. DEMARTINO, J. A., VAN RIPER, G., SICILIANO, S. J., MOLINEAUX, C. J., KONTEATIS, Z. D., ROSEN, H. AND SPRINGER, M. S.: The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. J. Biol. Chem. 269: 14446-14450, 1994.
6. DEVANE, W. A., HANUS, L., BREUER, A., PERTWEE, R. G., STEVENSON, L. A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. AND MECHOULAM, R.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949, 1992.
7. EVANS, D. M., LAKE, J. T., JOHNSON, M. R. AND HOWLETT, A. C.: Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization. J. Pharmacol. Exp. Ther. 268: 1271-1277, 1994.
8. FELDER, C. C., JOYCE, K. E., BRILEY, E. M., MANSOURI, J., MACKIE, K., BLOND, O., LAI, Y., MA, A. L. AND MITCHELL, R. L.: Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 48: 443-450, 1995.
9. FRÖDIN, M., PERALDI, P. AND VAN OBBERGHEN, E.: Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J. Biol. Chem. 269: 6207-6214, 1994.
10. GAYLE, R. B. I., SLEATH, P. R., SRINIVASON, S., BIRKS, C. W., WEERAWARNA, K. S., CERRETTI, D. P., KOZLOSKY, C. J., NELSON, N., BOS, T. V. AND BECKMANN, M. P.: Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. J. Biol. Chem. 268: 7283-7289, 1993.
11. GÉRARD, C. M., MOLLEREAU, C., VASSART, G. AND PARMENTIER, M.: Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279: 129-134, 1991.
12. GRAHAM, F. L. AND VAN DER EB, A. J.: Transformation of rat cells by DNA of human adenovirus 5. Virology 54: 536-539, 1973.
13. HOLTMANN, M. H., HADAC, E. M. AND MILLER, L. J.: Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J. Biol. Chem. 270: 14394-14398, 1995.
14. HOWLETT, A. C., CHAMPION-DOROW, T. M., MCMAHON, L. L. AND WESTLAKE, T. M.: The cannabinoid receptor: biochemical and cellular properties in neuroblastoma cells. Pharmacol. Biochem. Behav. 40: 565-569, 1991.
15. HOWLETT, A. C. AND FLEMING, R. M.: Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol. 26: 532-538, 1984.
16. JÜPPNER, H., SCHIPANI, E., BRINGHURST, F. R., MCCLURE, L., KEUTMAN, H. T., POTTS, J. T. J., KRONENBERG, H. M., ABOU-SAMRA, A. B., SEGRE, G. V. AND GARDELLA, T. J.: The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34). Endocrinology 134: 879-884, 1994.
17. KAMINSKY, N. E., ABOOD, M. E., KESSLER, F. K., MARTIN, B. R. AND SCHATZ, A. R.: Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42: 736-742, 1992.
18. ras. Proc. Natl. Acad. Sci. U.S.A. 91: 12706-12710, 1994.
19. LUPKER, J. H., ROSKAM, W. G., MILOUX, B., LIAUZUN, P., YANIV, M. AND JOUANNEAU, J.: Abundant excretion of human growth hormone by recombinant-plasmid-transformed monkey kidney cells. Gene 24: 281-287, 1983.
20. MACKIE, K. AND HILLE, B.: Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U.S.A. 89: 3825-3829, 1992.
21. MATSUDA, L. A., LOLAIT, S. J., BROWNSTEIN, M. J., YOUNG, A. C. AND BONNER, T. I.: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
22. MILLER, A. S. AND WALKER, J. M.: Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. Eur. J. Pharmacol. 279: 179-185, 1995.
23. MILOUX, B. AND LUPKER, J. H.: Rapid isolation of highly productive recombinant Chinese Hamster Ovary cell lines. Gene 149: 341-344, 1994.
24. MIYAKE, A.: A truncated isoform of human CCK-B/gastrin receptor generated by alternative use of a novel exon. Biochem. Biophys. Res. Commun. 208: 230-237, 1995.
25. MUNRO, S., THOMAS, K. L. AND ABU-SHAAR, M.: Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65, 1993.
26. PETTIT, D. A. D., SHOWALTER, V. M., ABOOD, M. E. AND CABRAL, G. A.: Expression of a cannabinoid receptor in baculovirus-infected insect cells. Biochem. Pharmacol. 48: 1231-1243, 1994.
27. RINALDI-CARMONA, M., BARTH, F., HÉAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NÉLIAT, G., CAPUT, D., FERRARA, P., SOUBRIÉ, P., BRELIÈRE, J.-C. AND LE FUR, G.: SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350: 240-244, 1994.
28. RINALDI-CARMONA, M., BARTH, F., HÉAULME, M., ALONSO, R., SHIRE, D., CONGY, C., SOUBRIÉ, P., BRELIÈRE, J.-C. AND LE FUR, G.: Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56: 1941-1947, 1995.
29. SHIRE, D., CARILLON, C., KAGHAD, M., CALANDRA, B., RINALDI-CARMONA, M., LE FUH, G., CAPUT, D. AND FERRARA, P.: An amino terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270: 3726-3731, 1995.
30. SHIRE, D., CALANDRA, B., DELPECH, M., DUMONT, X., KAGHAD, M., LE FUR, G., CAPUT, D. AND FERRARA, P.: Strutural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J. Biol. Chem. 271: 6941-6946, 1996.
31. SHIRE, D., CALANDRA, B., RINALDI-CARMONA, M., OUSTRIC, D., PESSEGUE, B., BONNIN, O., LE FUR, G., CAPUT D., AND FERRARA, P.: Molecular cloning, expression and function of the murine C. B.2 peripheral cannabinoid receptor. Biochem. Biophys. Acta, in press.
32. SICILIANO, S. J., ROLLINS, T. E., DEMARTINO, J., KONTEATIS, Z., MALKOWITZ, L., VAN RIPER, G., BONDY, S., ROSEN, H. AND SPRINGER, M. S.: Two-site binding of C5a by its receptor: An alternative binding paradigm for G protein-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 91: 1214-1218, 1994.
33. SLIPETZ, D., O'NEILL, G., FAVREAU, L., DUFRESNE, C., GALLANT, M., GAREAU, Y., GUAY, D., LABELLE, M. AND METTERS, C.: Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol. Pharmacol. 48: 352-361, 1995.
34. SPECTOR, T.: Refinement of the coomassie blue method of protein quantification. Anal. Biochem. 86: 142-146, 1975.
35. SUZUKI, H., PRADO, G. N., WILKINSON, N. AND NAVARRO, J.: The N terminus of interleukin-8 (IL-8) receptor confers high affinity binding to human IL-8. J. Biol. Chem. 269: 18263-18266, 1994.
36. TAKAHASHI, K., TSUCHIDA, K., TANABE, Y., MASU, M. AND NAKANISHI, S.: Role of the large extracellular domain of metabotropic glutamate receptors in agonist selectivity determination. J. Biol. Chem. 268: 19341-19345, 1993.
37. WARTMAMN, M., CAMPBELL, D., SUBRAMANIAN, A., BURSTEIN, S. H. AND DAVIS, R.: The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett. 359: 133-136, 1995.
38. WESTLAKE, T. M., HOWLETT, A. C., BONNER, T. I., MATSUDA, L. A., AND HERKENHAM, M.: Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63: 637, 1994.